News blog

Early promise for human embryonic stem cell therapy

Posted on behalf of Corie Lok Two clinical trials testing retinal cells derived from human embryonic stem cells report positive preliminary results today. A paper published today in The Lancet says that the cells appear to be safe four months after being injected into the eyes of two blind patients, and also describes visual improvements in the patients. This isn’t the first trial of human embryonic stem cell-based therapies, nor is it the first human data on these therapies. It is, however, the first – albeit early – data from the only ongoing clinical trial of such a treatment. One 


Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.